Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05680337
Other study ID # #6
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 1, 2022
Est. completion date July 1, 2025

Study information

Verified date June 2024
Source Bakulev Scientific Center of Cardiovascular Surgery
Contact Vladimir Shvartz
Phone +79032619292
Email vashvarts@bakulev.ru
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Transcutaneous electrical stimulation of the auricular vagus nerve (TENS) is a promising method of neuromodulation of the autonomic nervous system in patients with various pathologies. The use of this method requires the determination of a reliable biomarker of successful activation of the vagus nerve using TENS. Currently, most studies focus on the assessment of heart rate variability (HRV) as a marker of the functioning of the autonomic nervous system. Despite the physiological justification of HRV as a biomarker for TENS, the data on the effects of TENS on HRV are ambiguous. In some studies, a significant decrease in the ratio of spectral characteristics (LF/HF) in active TENS was found in comparison with fictitious stimulation (sham), which indicated an increase in the parasympathetic component of HRV. However, other studies have not revealed an increase in HRV.


Description:

Transcutaneous vagus nerve stimulation (TENS) involves the stimulation of the left and/or right auricular branch of the vagus nerve in the area of the cymba concha with low-frequency electrical impulses. The auricular branch of the vagus nerve runs superficially, which makes it a favorable target for non-invasive stimulation techniques to modulate vagal activity. It gained popularity due to minimal side effects and low cost. This method is a new, cost-effective alternative to invasive cervical vagus nerve stimulation (iVNs), which is an FDA-approved treatment of depression resistant to the treatment, epilepsy and other pathologies. The use of TENS has shown similar positive results as iVNs, for example, in reducing symptoms in patients with depression and changing the early visual processing of negative emotional stimuli in adolescent depression. Similarly, positive effects of TENS have also been found in chronic pain and epilepsy. These similarities in effects can be explained by the similarity of brain network activation achieved by iVNs and TENS. The lack of similarity between behavioral studies and numerous theories of physiological processes in TENS make it necessary to determine a reliable biomarker of successful activation of the vagus nerve using TENS. Although many potential biomarkers have been proposed, most studies have focused on HRV. Despite the physiological justification of HRV as a biomarker for TENS, the data on the effects of TENS on HRV are ambiguous. In some studies, a significant decrease in the ratio of spectral characteristics (LF/HF) in active TENS compared to fictitious stimulation (sham) was found, indicating an increase in the parasympathetic component of HRV. However, other studies have not revealed an increase in HRV. Large methodological differences between studies, such as different stimulation devices, sides and places of stimulation, experimental schemes, reported HRV parameters and stimulation protocols, reduce comparability between studies. One of the most striking examples is the use of various control conditions. While in most studies active TENS are compared with imitation of the earlobe as an independent variable, as recommended, in some studies active stimulation of the tragus was compared with a control state without stimulation or with a fictitious state without stimulation when the electrode is placed on the ear, but no electric current is applied. The development of international agreed consensus guidelines on TENS research reporting should address these issues. Although TENS represents a potential treatment option for many disorders and it is an interesting tool for experimental research, it needs to be studied in an objective and reliable way before its true place as a neuro-immunomodulatory intervention can be determined. The investigators plan to conduct a study on the assessment of TENS on the dynamics of HRV parameters with reporting according to the international consensus document https://www.frontiersin.org/articles/10.3389/fnhum.2020.568051/full#B235


Recruitment information / eligibility

Status Recruiting
Enrollment 600
Est. completion date July 1, 2025
Est. primary completion date January 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Sinus rhythm at the time of registration Exclusion Criteria: - Frequent ventricular / supraventricular extrasystole, 2d/3d degree AV Block - Taking glucocorticosteroids in the last 1 month - Taking any antiarrhythmics, except beta blockers - Severe chronic renal or liver pathology

Study Design


Related Conditions & MeSH terms


Intervention

Device:
TENS
TENS stimulation will occur within 10 minutes. HRV parameters will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.

Locations

Country Name City State
Russian Federation Federal Center for Cardiovascular Surgery (Astrakhan) Astrakhan
Russian Federation State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital Krasnodar
Russian Federation Bakulev National Medical Research Center for Cardiovascular Surgery Moscow

Sponsors (3)

Lead Sponsor Collaborator
Bakulev Scientific Center of Cardiovascular Surgery Astrakhan Federal Centre For Cardiac Surgery, State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital

Country where clinical trial is conducted

Russian Federation, 

References & Publications (2)

Shvartz V.A., Sizhazhev E.M. Percutaneous stimulation of the auricular branch of the vagus: the potential of the method of treatment of different cardiovascular diseases. Clinical Physiology of Circulation. 2023; 20 (1): 5-15 (in Russ.). DOI: 10.24022/181

Shvartz, V.; Sizhazhev, E.; Sokolskaya, M.; Koroleva, S.; Enginoev, S.; Kruchinova, S.; Shvartz, E.; Golukhova, E. The Effect of Short-Term Transcutaneous Electrical Stimulation of Auricular Vagus Nerve on Parameters of Heart Rate Variability. Data 2023,

Outcome

Type Measure Description Time frame Safety issue
Primary Dynamics of LF/HF Changes in the level of LF /HF relative to the initial and after the end of stimulation in the groups of active and fictitious stimulation This parameter will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.
Secondary HR dynamics Changes in the HR level relative to the initial and after the end of stimulation in the groups of active and fictitious stimulation This parameter will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.
Secondary Dynamics of SDNN Changes in the level of SDNN relative to the initial and after the end of stimulation in the groups of active and fictitious stimulation This parameter will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.
Secondary Dynamics of IVB Changes in the level of IVB relative to the initial and after the end of stimulation in the groups of active and fictitious stimulation This parameter will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.
Secondary Dynamics of IC1 Changes in the level of IC1 relative to the initial and after the end of stimulation in the groups of active and fictitious stimulation. IC1 (Index Centralization) = (HF+LF)/VLF This parameter will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.
Secondary Dynamics of IC2 Changes in the level of IC2 relative to the initial and after the end of stimulation in the groups of active and fictitious stimulation. IC2 (Index Centralization) = (VHF+LF)/LF This parameter will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.
Secondary Dynamics of HF% Changes in the level of HF% relative to the initial and after the end of stimulation in the groups of active and fictitious stimulation This parameter will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.
Secondary Dynamics of LF% Changes in the level of LF% relative to the initial and after the end of stimulation in the groups of active and fictitious stimulation This parameter will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.
Secondary HF dynamics Changes in the HF level relative to the initial and after the end of stimulation in the groups of active and fictitious stimulation This parameter will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.
Secondary Dynamics of LF Changes in the level of LF relative to the initial and after the end of stimulation in the groups of active and fictitious stimulation This parameter will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.
See also
  Status Clinical Trial Phase
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Recruiting NCT04554160 - Arrhythmias in Pulmonary Hypertension Assessed by Continuous Long-term Cardiac Monitoring
Completed NCT02153385 - Effects of Yoga on Heart Rate Variability and Mood in Women N/A
Terminated NCT04381182 - Heart Rate Variability and Stress Management Enhancement N/A
Active, not recruiting NCT04342078 - Vitamin D and Health Outcomes in Preterm Born Population
Completed NCT03068182 - Effects of Arm Crank Versus Treadmill Exercises on Heart Rate Variability in Adult Subjects. N/A
Recruiting NCT06101225 - Effects of a Relaxation and Guided Imagery Intervention in School Context N/A
Recruiting NCT05679882 - Effects of Natural Sounds on Attention Restoration Outdoors N/A
Recruiting NCT05950698 - Obesity and Bariatric Surgery According to a Biopsychosocial Perspective.
Completed NCT05093439 - Heart Rate Variability at the Emergency Department
Completed NCT04487899 - Analysis of Heart Rate Variability During Emergency Flight Simulator Missions in Fighter Pilots
Recruiting NCT05560893 - The Heart of the Community Study N/A
Completed NCT04869176 - Effect of Caffeine on Heart Rate Variability in Newborns N/A
Recruiting NCT06425939 - Exploring the Relationship Between Heart Rate Variability (HRV), Training Load, and Exercise Performance N/A
Recruiting NCT05869721 - Effects of Yoga on Women With Breast Cancer N/A
Recruiting NCT06450483 - Compare the Effects of Different AVNS Parameters on Neck Pain, HRV, Balance in Collegiate Atheletes N/A
Completed NCT02137057 - The Effect of Spinal Anesthesia on Heart Rate Variability in Diabetic Patients N/A
Completed NCT01908920 - Osteopathic Manipulative Treatment Effects on High Frequency Parameters in Healthy Subjects N/A
Not yet recruiting NCT05296616 - Sleep Quality, Stress Level and Heart Rate Variability of University Students N/A
Recruiting NCT04826601 - The Physical and Psychologic Effects of Aromatherapy in Cancer Patients During Chemotherapy N/A